- Home
- PLSE vs PRGS Comparison
PLSE vs PRGS Comparison
Compare PLSE & PRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | PRGS |
|---|---|---|
| Founded | 2014 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PLSE | PRGS |
|---|---|---|
| Price | $26.47 | $29.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $22.00 | ★ $49.50 |
| AVG Volume (30 Days) | 353.3K | ★ 608.4K |
| Earning Date | 05-07-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.79 |
| EPS | N/A | ★ 0.53 |
| Revenue | N/A | ★ $397,572,000.00 |
| Revenue This Year | $840.00 | $3.70 |
| Revenue Next Year | $287.54 | $1.08 |
| P/E Ratio | ★ N/A | $56.08 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.56 | $23.82 |
| 52 Week High | $27.98 | $65.50 |
Technical Indicators
Market Signals| Indicator | PLSE | PRGS |
|---|---|---|
| Relative Strength Index (RSI) | 60.74 | 53.72 |
| Support Level | $17.58 | $26.18 |
| Resistance Level | $27.14 | $29.99 |
| Average True Range (ATR) | 1.78 | 1.34 |
| MACD | 0.39 | 0.28 |
| Stochastic Oscillator | 78.48 | 86.96 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About PRGS Progress Software Corporation (DE)
Progress Software Corp provides software operate in one operating segment: software products for the development, deployment, and management of responsible, AI-powered applications and digital experiences. The following are products: Chef, Corticon, Data Direct, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, WhatsUp Gold. Geographical regions include the United States, Canada, EMEA, Latin America, and Asia Pacific.